- Home
- BLIV vs COEP Comparison
BLIV vs COEP Comparison
Compare BLIV & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLIV
- COEP
- Stock Information
- Founded
- BLIV 2014
- COEP 2017
- Country
- BLIV Singapore
- COEP United States
- Employees
- BLIV N/A
- COEP N/A
- Industry
- BLIV
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLIV
- COEP Health Care
- Exchange
- BLIV NYSE
- COEP Nasdaq
- Market Cap
- BLIV 39.8M
- COEP 39.0M
- IPO Year
- BLIV 2025
- COEP N/A
- Fundamental
- Price
- BLIV $4.27
- COEP $9.50
- Analyst Decision
- BLIV
- COEP
- Analyst Count
- BLIV 0
- COEP 0
- Target Price
- BLIV N/A
- COEP N/A
- AVG Volume (30 Days)
- BLIV 173.4K
- COEP 103.6K
- Earning Date
- BLIV 01-01-0001
- COEP 05-20-2025
- Dividend Yield
- BLIV N/A
- COEP N/A
- EPS Growth
- BLIV N/A
- COEP N/A
- EPS
- BLIV N/A
- COEP N/A
- Revenue
- BLIV $1,915,838.00
- COEP N/A
- Revenue This Year
- BLIV N/A
- COEP N/A
- Revenue Next Year
- BLIV N/A
- COEP N/A
- P/E Ratio
- BLIV N/A
- COEP N/A
- Revenue Growth
- BLIV N/A
- COEP N/A
- 52 Week Low
- BLIV $2.69
- COEP $2.31
- 52 Week High
- BLIV $6.40
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- BLIV N/A
- COEP 51.27
- Support Level
- BLIV N/A
- COEP $7.81
- Resistance Level
- BLIV N/A
- COEP $11.17
- Average True Range (ATR)
- BLIV 0.00
- COEP 1.39
- MACD
- BLIV 0.00
- COEP -0.05
- Stochastic Oscillator
- BLIV 0.00
- COEP 51.92
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.